Clinical trial · Interventional
Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resection
NCT06017661CI-TRIAL-00070075unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to demonstrate, under clinical conditions, the effectiveness of the standard product 'Nutridrink' enriched with a mixture of plant extracts rich in polyphenolic compounds in the aspect of supporting the recovery of oncology patients undergoing surgical resection of tumours.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Immunomodulation | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nutridrink Skin Repair | Dietary Supplement | — | UNRESOLVED |
| Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds
- description
- Group of 15 patients undergoing surgical resection of tumour
- interventionNames
- Dietary Supplement: Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds
- type
- ACTIVE_COMPARATOR
- label
- Nutridrink Skin Repair
- description
- Group of 15 patients undergoing surgical resection of tumour
- interventionNames
- Dietary Supplement: Nutridrink Skin Repair
Primary outcomes (4)
- measure
- SOD level
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Women and men, 18-80 years old * Patients diagnosed with resectable gastrointestinal tract cancer undergo the resection procedure no later than one month after being enrolled in the study * Signed informed consent Exclusion Criteria: * Intake of supplements containing plant extracts, polyphenols or anthocyanins * Participation in another clinical trial * Inability to consume the investigational product in liquid form as medication/placebo * Women who are pregnant, planning to become pregnant during the study or breastfeeding * Autoimmune disease, severe liver dysfunction, inflammatory bowel disease, tuberculosis, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplantation * Hypersensitivity/allergy to any of the ingredient
References
Publications (0)
Data not yet available
No reference posted for this study.